as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
2.79%
Downside
17.72%
Upside
52 Week's Low
52 Week's High
71.36%
Downside
20.39%
Upside
Check Trevi Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.0B
EPS (TTM)
-0.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-51.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
32442200.00%
Compare market cap, revenue, PE, and other key metrics of Trevi Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.0B | NA | NA | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Trevi Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Trevi Therapeutics Inc investment value today
Current value as on today
₹2,49,649
Returns
₹1,49,649
(+149.65%)
Returns from Trevi Therapeutics Inc Stock
₹1,44,510 (+144.51%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Trevi Therapeutics Inc. Average target price of $20.6
Get share price movements and forecasts by analysts on Trevi Therapeutics Inc.
What analysts predicted
60%UPSIDE
Target Price
$20.6
Current Price
$8.24
Analyzed by
12 Analysts
Target
$20.60
Trevi Therapeutics Inc target price $20.6, a slight upside of 60% compared to current price of $8.24. According to 12 analysts rating.
Search interest for Trevi Therapeutics Inc Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, TRVI has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 7 days, TRVI stock has moved up by 17.7%
Organisation | Trevi Therapeutics Inc |
Headquarters | 195 Church Street, New Haven, CT, United States, 06510 |
Industry | Pharmaceuticals: Major |
CEO | Ms. Jennifer L. Good |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Katie McManus | Communications Manager |
Mr. Farrell Simon Pharm.D. | Chief Commercial Officer |
Ms. Katherine Takaki Ph.D. | Senior VP of Global Regulatory Affairs |
Ms. Jennifer L. Good | Co-Founder, CEO, President, Interim Principal Financial Officer & Director |
Dr. James V. Cassella Ph.D. | Chief Development Officer |
Dr. Thomas R. Sciascia M.D. | Co-Founder & Chief Scientific Officer |
Mr. Christopher Galletta | Controller & Chief Accounting Officer |
Trevi Therapeutics Inc share price today is $8.24 as on at the close of the market. Trevi Therapeutics Inc share today touched a day high of $9.7 and a low of $8.01.
Trevi Therapeutics Inc share touched a 52 week high of $9.92 on and a 52 week low of $2.36 on . Trevi Therapeutics Inc stock price today i.e. is closed at $8.24,which is 16.94% down from its 52 week high and 249.15% up from its 52 week low.
Trevi Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Trevi Therapeutics Inc (TRVI) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Trevi Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Trevi Therapeutics Inc share’s latest price of $8.24 as on September 13, 2025 at 1:29 am IST, you will get 1.2136 shares of Trevi Therapeutics Inc. Learn more about
fractional shares .